Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis

doi:10.3748/wjg.v19.i36.6069

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 36

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3758)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

342

HTML

2864

Figures (1-3)

331

Tables (1-3)

221

Sum=3758

Sep 28, 2013 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 28, 2013; 19(36): 6069-6076
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.6069

Full Size Figure Download Figure

Figure 3 Glycyrrhizinate indirectly reduced portal hypertension. Gly: Diammonium glycyrrhizinate; TPV: Terminal portal venule; NOX: Nicotinamide adenine dinucleotide oxidase; OO^-: Superoxide; iNOS: Inducible nitric oxide synthase; NO: Nitric oxide; ONOO^-: Peroxynitrite; Gly: Glycyrrhizinate.

Citation: Zhao X, Deng B, Xu XY, Yang SJ, Zhang T, Song YJ, Liu XT, Wang YQ, Cai DY. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis. World J Gastroenterol 2013; 19(36): 6069-6076
URL: https://www.wjgnet.com/1007-9327/full/v19/i36/6069.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i36.6069